Log in to save to my catalogue

The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of...

The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c061f35df32c4ea692b1d763653a2a6a

The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery

About this item

Full title

The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery

Publisher

Basel: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2022-09, Vol.12 (9), p.1229

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Endometrial cancer (EC) is the most common gynecological neoplasm in high-income countries. Five-year survival rates are related to stage at diagnosis, but currently, no validated screening tests are available in clinical practice. The metabolome offers an unprecedented overview of the molecules underlying EC. In this study, we aimed to validate a...

Alternative Titles

Full title

The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c061f35df32c4ea692b1d763653a2a6a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c061f35df32c4ea692b1d763653a2a6a

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom12091229

How to access this item